Venmax Drugs & Pharmaceuticals Ltd

NSE: VENMAX · BSE: 531015 · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹14.89
Market cap: ₹13.08 Cr
Revenue (annual): ₹8.02 Cr
Net profit (annual): ₹0.25 Cr
P/E (TTM): 46.7×Sector 47.3×
Promoter holding: 10.46%-3.34% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Board Meeting Date 3 Capital Structure Change 2 Acquisition 2 Debt & Borrowing 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 Apr 2026 16:29 IST BSE

Debt & Borrowing

Venmax Drugs & Pharmaceuticals Debt & Borrowing

Venmax Drugs and Pharmaceuticals Ltd (BSE: 531015) confirmed it does not meet the SEBI 'Large Corporate' criteria as of March 31, 2026. The company reported zero outstanding borrowings and a nil credit rating for the period. This routine regulatory disclosure clarifies the company's borrowing framework status for investors.

Read the filing ↗